Does Shockwave Therapy Increase Size?

No rigorous clinical trial has demonstrated that shockwave therapy produces a meaningful, lasting increase in penile size. The treatment is widely studied for erectile dysfunction, where improved blood flow can make erections firmer and fuller, but that is a functional change rather than a structural gain in tissue dimensions. A single published case report documented about a centimeter of stretched-length increase, but one patient is not evidence of a reliable effect. The gap between marketing claims and peer-reviewed data is wide on this question, and understanding why requires looking at what shockwave therapy actually does to tissue.

What Shockwave Therapy Does at the Tissue Level

Low-intensity shockwave therapy, often abbreviated LiSWT or LiESWT, sends acoustic pressure waves into tissue. These waves are not strong enough to break anything apart the way kidney-stone lithotripsy does. Instead, they trigger a cascade of biological responses. In animal studies, the treatment consistently boosts two key growth signals in penile tissue: vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS). Both of these help form new small blood vessels, a process called angiogenesis. In diabetic rats whose penile blood-vessel function had been damaged, shockwave treatment brought VEGF levels close to normal and significantly raised eNOS levels compared to untreated diabetic animals.¹ Similar results appear in aging rat models, where the treatment increased these same vascular markers along with smooth-muscle actin, a protein that helps blood vessels contract properly.²

Another line of research shows that shockwave therapy can activate progenitor cells, essentially dormant repair cells sitting in penile tissue. One study observed that after treatment, cell division markers lit up in the walls of small blood vessels, including capillaries and arterioles, suggesting the endothelial lining was actively regenerating.³ This is meaningful for restoring blood flow to damaged erectile tissue, but activating repair cells in blood-vessel walls is not the same thing as generating new bulk tissue. The penis is not a muscle, and the type of regeneration seen here is vascular, not volumetric.

Why Better Erections Can Be Mistaken for Larger Size

The erectile chambers of the penis fill with blood during arousal, and how firm and full they get depends largely on vascular health. If shockwave therapy improves microcirculation and restores some of the blood-vessel network that has degraded with age or disease, a man could experience noticeably firmer erections. A firmer erection looks and feels larger than a soft one, even though the underlying tissue dimensions have not changed. This is the most likely explanation for anecdotal reports of “size gains” after treatment.

An umbrella review covering multiple systematic reviews and meta-analyses found that low-intensity shockwave therapy does improve erectile function scores and penile hardness in men with vascular-origin erectile dysfunction.⁴ Better hardness at erection means more complete engorgement of the existing tissue. If someone’s erections had been only partially rigid before treatment, reaching fuller rigidity afterward would produce a genuinely larger erect measurement, but only in the sense that the penis is now reaching its actual capacity rather than exceeding it.

This distinction matters because many clinics market shockwave therapy by conflating erectile improvement with permanent growth. They are different things. One is restoring function; the other would require building new structural tissue.

The Only Published Size Data

As of now, there is exactly one published case report documenting a dimensional change in penile length following shockwave therapy. In it, a man treated with low-intensity shockwaves saw his stretched penile length go from 11.5 cm to 12.5 cm by the fourth session, settling at 12.0 cm at an eight-month follow-up. Even with that gain, his rigidity remained inadequate for intercourse, and he still required injections to achieve a functional erection.⁵

A single case report is the lowest rung of clinical evidence. The patient may have had unique circumstances. The measurement could have been influenced by technique, timing, or who held the ruler. And importantly, the gain was in stretched flaccid length, not erect length. Research on penile measurement has shown that flaccid measurements, including stretched ones, are only moderately accurate in predicting erect size and are significantly dependent on who does the measuring.⁶ A centimeter of difference easily falls within the range of observer variability, especially across sessions weeks apart.

No randomized controlled trial has set out to measure whether shockwave therapy changes penile dimensions as a primary outcome. Until that happens, there is no credible basis for claiming the treatment increases size.

What About Peyronie’s Disease?

Peyronie’s disease involves fibrous plaques forming inside the tunica albuginea, the tough sheath surrounding the erectile chambers. These plaques can cause penile curvature, pain, and sometimes shortening, so treatments that reduce plaque size or curvature could, in theory, restore lost length. Shockwave therapy has been studied for Peyronie’s more than for any other penile structural question.

A systematic review of randomized controlled trials found that shockwave therapy did not show a statistically significant benefit for curvature reduction, plaque size, or erectile function in Peyronie’s patients, though one meta-analysis within the review did suggest some benefit for plaque reduction.⁷ The picture gets more nuanced when looking at timing. A single-center study treating men in the early inflammatory phase of Peyronie’s found that median plaque size dropped from 2 cm to 1.2 cm and median penile curvature went from 31 degrees to 17 degrees, though neither of those changes quite reached statistical significance. Pain scores, on the other hand, dropped sharply and significantly.⁸

So if you have Peyronie’s disease and your penis has curved or shortened because of scar tissue, shockwave therapy might help reduce pain and could modestly improve curvature, especially early in the disease. But this is about reversing a pathological loss, not about making a healthy penis longer. And even for that specific use, the data is mixed enough that many urologists consider it a second-line option rather than a first choice.

Focused Versus Radial Devices

Not all shockwave devices work the same way. The two main types are focused shockwave therapy, which concentrates energy at a specific depth in tissue, and radial shockwave therapy, which disperses energy from the skin surface inward. The distinction matters for outcomes. A meta-analysis comparing the two modalities found that focused shockwave therapy produced better erectile function improvements than radial therapy, with a moderate-sized advantage across standardized questionnaire scores.⁹

This matters for the size question because many at-home or clinic-based devices marketed for “male enhancement” use radial technology, which is cheaper to manufacture and does not require the same precision in application. If the stronger evidence for erectile improvement comes from focused devices used in controlled clinical settings, the leap to radial devices used in a strip-mall wellness clinic is significant. The biological effects documented in the animal and cell studies described earlier used carefully calibrated energy doses. The parameters matter enormously: energy density, number of pulses, frequency of sessions, and total treatment duration all influence whether the tissue responds with beneficial remodeling or simply absorbs the energy without meaningful change.

How Long Do Effects Last?

Even for the well-studied endpoint of erectile function, the durability of shockwave therapy’s effects is a real concern. A systematic review of long-term outcomes found that erectile function scores improved significantly at six months, with a median gain of about five points on a standardized scale. But at twelve months, two out of five studies saw results plateau and three saw scores decline, though all patients still scored above their pre-treatment baselines.¹⁰

If the functional improvements from new blood vessel formation start fading within a year for many patients, any downstream size effect, assuming one existed, would presumably follow the same trajectory. The vascular remodeling triggered by shockwave therapy does not appear to be a one-and-done permanent change for most people. It may require maintenance sessions, and the optimal schedule for maintenance is not well established.

What Shockwave Therapy Does to Other Tissues

Outside the urology world, shockwave therapy has a longer track record in orthopedics and sports medicine, where it is used on tendons, muscles, and bones. These studies provide useful context for what the treatment can and cannot do structurally.

In skeletal muscle, shockwave therapy accelerates regeneration after injury. An animal study found that treated muscles had significantly larger regenerating fibers and higher numbers of activated satellite cells, the stem cells responsible for muscle repair, compared to untreated muscles at both four and seven days after injury.¹¹ Another study confirmed that radial shockwave therapy promoted the expression of muscle differentiation genes and the formation of new muscle fibers after injury in rats.¹² However, in at least one study, while gene-expression markers of satellite cell activation went up early, the actual number of cells expressing those markers did not differ between treated and untreated groups, suggesting the activation signal does not always translate into more cells.¹³

In tendons, the effects are similarly about remodeling rather than growth. Shockwave therapy upregulates collagen production and certain growth factors in tendon cells.¹⁴ But it can also temporarily disorganize normal collagen structure. One study on horse tendons found that three hours after treatment, collagen was visibly disorganized and degraded collagen levels had increased. By six weeks, the degraded collagen had decreased and new collagen genes were upregulated, suggesting a repair-and-remodel cycle.¹⁵ In fibroblasts, the cells that build connective tissue, shockwave exposure enhances proliferation and boosts production of collagen types I and III along with a key growth factor.¹⁶

The pattern across all these tissues is consistent: shockwave therapy is good at repair, remodeling, and improving blood supply. It can help damaged tissue recover and can stimulate collagen turnover. What it does not do, in any tissue studied, is cause healthy tissue to grow beyond its normal dimensions. There is no evidence in any organ system that shockwave therapy makes a healthy structure bigger than it was before.

The Marketing Problem

Despite the thin evidence, a thriving industry of clinics and at-home device manufacturers markets shockwave therapy specifically for penile enlargement. Prices in the United States commonly range from a few hundred dollars per session for in-clinic treatment to several thousand for a full course. At-home radial devices sell for anywhere from a few hundred to over a thousand dollars. The marketing typically cites the legitimate animal studies on angiogenesis and progenitor cell activation described earlier, then makes an inferential leap: if the treatment grows new blood vessels and activates stem cells, it must make the penis bigger.

That leap is not supported by the data. Growing new capillaries inside existing erectile tissue improves the tissue’s ability to fill with blood. It does not expand the outer walls of the organ. The tunica albuginea, the fibrous sheath that defines the penis’s external dimensions, is an extraordinarily tough collagen structure. Making it expand permanently would require either stretching it beyond its elastic limit or adding new structural material to it. Shockwave therapy does neither of those things based on any current evidence.

Some clinics combine shockwave therapy with platelet-rich plasma injections, vacuum pumps, or traction devices and attribute any perceived gains to the shockwave component. Without controlled trials isolating each treatment’s contribution, these combination protocols make it impossible to know what, if anything, is doing what.

What the Animal Research Actually Suggests for the Future

The animal data is genuinely interesting for reasons that have nothing to do with size. The fact that shockwave therapy can revive microcirculation in damaged erectile tissue and activate dormant progenitor cells opens doors for treating men with vascular erectile dysfunction, diabetes-related sexual dysfunction, and possibly post-surgical nerve and tissue damage. Studies in naturally aged rats show that the treatment restores angiogenic markers that decline with aging, suggesting a potential intervention for age-related changes in erectile quality.¹⁷

Researchers are also exploring whether shockwave therapy could enhance the survival and integration of stem cells injected into penile tissue, a combination approach that might one day enable genuine tissue expansion. But that work is early-stage and entirely preclinical. The honest state of the science is that shockwave therapy is a promising tool for vascular repair in erectile tissue, a modestly useful option for Peyronie’s pain, and an unproven intervention for anything related to penile dimensions. If a clinic is charging thousands of dollars with the promise of permanent size increases, the evidence does not back the price tag.